Viewing Study NCT01007292


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2026-02-02 @ 4:24 AM
Study NCT ID: NCT01007292
Status: COMPLETED
Last Update Posted: 2015-10-19
First Post: 2009-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
Sponsor: Astellas Pharma Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Hodgkin's Lymphoma View
None relapsed View
None CD20-Positive View
None YM155 View